Full-Service Clinical Trials in Central and Eastern Europe

OCT is a local CRO providing high-quality services in clinical trials conduct in the CEE region.

Our 65 people strong highly professional clinical team includes only medical doctors in Russia, Ukraine, Bulgaria, Belarus, Baltic States, Poland and Czech Republic.

OCT expertise covers a broad range of therapeutic areas due to the accumulated experience of our staff.

We are dedicated to speedy recruitment, timely project implementation and individual approach.

 

OCT is launching in Russia a phase II clinical trial in 130 metastatic breast cancer patients.

 

Phase I/II trial in solid tumors in 2 sites in Russia

 

Additional sites in Russia and Ukraine in Phase III ovarian cancer trial opened

 

Phase III trial in orthopedic interventions in 7 sites in Russia started

 

OCT QA department starts 3d round of investigator GCP trainings for Novartis

 

Phase IV trial in rhinitis in 8 sites in Russia started

 

A device trial in surgery in Baltic States started

 

A phase III trial in mastocytosis started

 

OCT started collaboration with RUSNANO

 

A phase IV pediatric trial in acute bronchitis started

 

A phase III trial in endometrial cancer in 6 sites in Russia and Estonia started.

 

Enrolment of 1223 patients in 11 sites across Russia completed

 

OCT started phase III trial in breast cancer in 10 sites in Russia

 

OCT signed an exclusive collaboration agreement

 

OCT QA department starts investigator GCP training for Novartis

 

OCT is starting a new diabetes trial in 10 sites in Russia

 

OCT is initiating breast cancer trial in Russia

 

Partnerships in Clinical Trials 2010 – Vienna, Austria, Booth 310

 

35th ESMO Congress – Milan, Italy, Booth 97

 

ASCO Annual Meeting 2010 — Chicago, USA. Booth 23102

 

46th Annual DIA Meeting 2010 — Washington, USA. Booth 844

 

19th Annual "Partnerships in Clinical Trials" 2010 — Orlando, USA. Booth 557

 

AACR 101st Annual Meeting 2010. Booth 525

 

ACRP 2010 — Florida, USA. Booth 227

“OCT vision is to be recognized by pharmaceutical and biotech companies as one of the leaders in providing clinical trial services in Eastern Europe and Russia, a reliable partner, a solidary team of professionals, and CRO they want to collaborate with once again. Our core values are satisfied sponsors and investigators, international strategic long term CRO partnership, high quality data/services, flexible and customized approach, experienced and trained company staff”, — Dmitry Sharov, General Manager of OCT.